Korea Stock Market Wrap: 5 Signals After the July 24 Selloff

The Korea stock market wrap for July 24, 2026 was dominated by an unusually sharp risk-off move. Both major indices fell more than 5% as weakness in global technology stocks, concerns about heavy AI capital spending, and rising oil prices pressured investor sentiment.

However, the session was not a simple story of indiscriminate selling. Biopharma, shipbuilding, home appliances, and several order-driven stocks displayed meaningful relative strength, offering clues about where investors were still willing to take risk.

Korea stock market wrap for July 24 2026 showing KOSPI KOSDAQ biopharma and shipbuilding stocks

Korea Market Wrap — July 24, 2026

1. KOSPI and KOSDAQ Suffered a Broad Selloff

KOSPI 6,690.62 · -5.72%

KOSDAQ 748.22 · -5.32%

The KOSPI closed at 6,690.62, while the KOSDAQ ended at 748.22. Semiconductor heavyweights led the decline. SK hynix dropped 8.34%, and Samsung Electronics fell 7.59%, reflecting renewed concern about AI-related spending, memory competition, and the global technology cycle.

The key point in this Korea stock market wrap is that the decline was broad enough to affect most growth sectors. Investors should therefore focus less on predicting an immediate index rebound and more on identifying companies supported by earnings, contracts, policy, or shareholder-return events.

2. Biopharma Became the Main Defensive Sector

Biopharma stocks stood out despite the market shock. Samsung Biologics surged 10.08% as its planned acquisition of PolyPeptide strengthened expectations for expansion into peptide-based drugs and the fast-growing GLP-1 supply chain. The company also reported that first-half operating profit exceeded KRW 1 trillion.

Samsung Biologics +10.08% — PolyPeptide acquisition and strong earnings
Yuhan +4.90% — KRW 425.3 billion treasury-share cancellation
HLB +4.33% — Progress in the FDA review of its FGFR2 cancer therapy
Peptron +4.14% — Expansion plan for Osong Plant 2

These gains were driven by company-specific events rather than general market optimism. That distinction matters because event-driven stocks can remain relatively resilient even when index volatility stays high.

3. Korea–U.S. Shipbuilding Cooperation Lifted Suppliers

Shipbuilding was another clear pocket of strength. The opening of the Korea–U.S. Shipbuilding Cooperation Center in Washington improved expectations for future orders, naval maintenance, repair and overhaul projects, workforce development, and joint research.

Hyundai Hims jumped 22.50%, Samyoung M-Tek gained 11.01%, and SK oceanplant rose 6.32%. The rally expanded beyond major shipbuilders into structures, engine components, castings, offshore facilities, and U.S. naval MRO-related suppliers.

        Investment takeaway: The shipbuilding theme is evolving from a traditional order-cycle story into a broader policy, defense, infrastructure, and supply-chain investment theme.
    

4. Weather and Commodity Themes Produced Sharp Movers

Extreme weather also created short-term trading opportunities. Winix soared 29.93% as late monsoon conditions and high humidity increased demand for dehumidifiers. PASECO climbed 15.23% on expectations for stronger seasonal appliance demand.

Korea Industry advanced 13.04% as global grain prices reached their highest level in roughly three years amid war, heat, and weather-related supply disruptions. In contrast, Rainbow Robotics plunged 17.62% after Samsung Electronics’ new RX organization was viewed as separate from a direct integration of the robotics company.

5. What Investors Should Watch Next

This Korea stock market wrap suggests that volatility may remain elevated. A sharp index decline can produce a technical rebound, but semiconductor weakness and uncertainty surrounding global AI investment remain important risks. Chasing an early rebound without confirming foreign flows, trading volume, and semiconductor stabilization could be dangerous.

Investors should instead watch three groups: profitable biopharma companies with identifiable catalysts, shipbuilding suppliers connected to Korea–U.S. cooperation, and companies with confirmed contracts or shareholder-return policies. Read the previous Korea stock market wrap for July 23 to compare how market leadership changed from one session to the next.

For additional context on Samsung Biologics’ peptide expansion, see the Reuters report on the PolyPeptide acquisition .

Bottom line: July 24 was a severe risk-off session, but it also revealed selective leadership. Rather than treating every falling stock as a bargain, investors should prioritize earnings visibility, policy support, confirmed orders, and clear corporate catalysts.